Galmed Pharma (GLMD) Tops Q3 EPS by 19c

Galmed Pharma (NASDAQ: GLMD) reported Q3 EPS of $0.05, $0.19 better than the analyst estimate of ($0.14).

For earnings history and earnings-related data on Galmed Pharma (GLMD) click here.

You May Also Be Interested In

• Shipping stocks on fire — but cracks are forming in the rate rally
• Corteva Inc. (CTVA) PT Lowered to $95 at BMO Capital
• Vitesse Energy closes $26M Denver-Julesburg Basin acquisition